Amplification of c-MET in Malignant Mesothelioma

被引：0
|
作者：
Fedeli, Franco
Varesano, Serena
Salvi, Sandra
Boccardo, Silmona
Truini, Mauro
Ferro, Paola
Canessa, Pier Aldo
Pistillo, Maria Pia
Roncella, Silvio
机构：
[1] ASL5, La Spezia, Italy
[2] IRCCS AOU San Martino IST, Genoa, Italy
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1905
引用
收藏
页码：475A / 476A
页数：2
相关论文
共 50 条
  • [21] Expression of the c-Met Proteins in Malignant Skin Cancers
    Lee, Yoon-Jin
    Kim, Dae-Hyun
    Lee, Sang-Han
    Kim, Dong-Wook
    Nam, Hae-Seon
    Cho, Moon Kyun
    ANNALS OF DERMATOLOGY, 2011, 23 (01) : 33 - 38
  • [22] The role of the HGF/c-Met signaling pathway in crizotinib-induced apoptosis in lung cancer with c-Met amplification
    Shaozhang Zhou
    Zhixin Dong
    Jinyi Lv
    Aiping Zeng
    Huilin Wang
    Ruiling Ning
    Xiangqun Song
    Oncology and Translational Medicine, 2017, 3 (03) : 116 - 126
  • [23] Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma
    Santoni-Rugiu, Eric
    Lu, Maya Jeje Schuang
    Jakobsen, Jan Nyrop
    Melchior, Linea Cecilie
    Ravn, Jesper
    Sorensen, Jens Benn
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [24] Treatments of NSCLC-PDX with c-MET gene amplification by c-MET inhibitors lead to rapid development of drug resistance
    Yang, Mengmeng
    Song, Xiaoming
    Cai, Jie
    Wang, Youzhu
    Chen, Taiping
    Wery, Jean-Pierre
    Chen, Yiyou
    Li, Henry
    CANCER RESEARCH, 2013, 73 (08)
  • [25] Immunohistochemical (IHC) expression of c-Met receptor tyrosine kinase (c-Met) has prognostic significance and its activation is related to phosphorylated protein kinase c β (p-PKC β) in malignant mesothelioma (MM)
    Westerhoff, M.
    Faoro, L.
    Loganathan, S.
    Salgia, R.
    Krausz, T.
    Husain, A. N.
    LABORATORY INVESTIGATION, 2008, 88 : 353A - 353A
  • [26] Immunohistochemical (IHC) expression of c-Met receptor tyrosine kinase (c-Met) has prognostic significance and its activation is related to phosphorylated protein kinase cβ (p-PKCβ) in malignant mesothelioma (MM)
    Westerhoff, M.
    Faoro, L.
    Loganathan, S.
    Salgia, R.
    Krausz, T.
    Husain, A. N.
    MODERN PATHOLOGY, 2008, 21 : 353A - 353A
  • [27] Hepatocyte growth factor scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor
    Klominek, J
    Baskin, B
    Liu, ZW
    Hauzenberger, D
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (02) : 240 - 249
  • [28] AXL, c-MET and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma.
    Zito Marino, F.
    Accardo, M.
    Poziello, G.
    Ronchi, A.
    Ciaramella, V.
    Vicidomini, G.
    Santini, M.
    Morgillo, F.
    Franco, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S759 - S759
  • [29] c-Met ectodomain shedding rate correlates with malignant potential
    Athauda, Gagani
    Giubellino, Alessio
    Coleman, Jonathan A.
    Horak, Christine
    Steeg, Patricia S.
    Lee, Ming-Jung
    Trepel, Jane
    Wimberly, Jennifer
    Sun, Jan
    Coxon, Angela
    Burgess, Teresa L.
    Bottaro, Donald P.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4154 - 4162
  • [30] Frequency and clinical characteristics of c-MET mutation in malignant melanoma
    Kim, Sharon
    Gonzalez, Nydia
    Luthra, Raja
    Aldape, Kenneth
    Zuo, Zhuang
    Liu, Ping
    Barron, David
    Kim, Kevin B.
    CANCER RESEARCH, 2012, 72
12345